Download Gail M. Humble - American Academy of Aesthetic Medicine

Gail M. Humble
Work Address
101 N. Pacific Coast Hwy Ste 102
Redondo Beach, CA 90277
310-379-4838
Education:
1973-1977
1977-1981
1981-1982
1982-1984
Home Address
3747 Palos Verdes Dr. N
Rolling Hills Est. CA, 90274
[email protected]
B.S Genetics with Honors University of California Davidson
University of Texas Medical Branch
Internship in General Surgery Michael Reese Medical Center
Residency in Anesthesiology University of Southern California
Post –Doctoral Positions:
2011- Present
Medical Director of Aesthetic Anti-Aging Institute Redondo Beach, Ca
2009-2011
Medical Director of Pure Skin & Laser Institute
1997-2011
Medical Director of Blue Pacific Aesthetic Medical Group
1995-1997
Medical Director of Kerlin Jobe Surgery Center
1992-1995
Chairman Dept. of Anesthesia, Medical Director Laser Surgery Center
1984-1992
Associate Clinical Professors, Medical Director of Surgicenter of the South Bay, Staff Member
Little Company of Mary Hospital, Staff Member Torrance Memorial Medical Center
Publications:
Humble G, Bassichis B,Blick Conant M, Gold M, Echavez M, Mest D, Injectable Poly-L-Lactic Acid for Human
Immunodeficiency Virus-Associated Facial Lipoatrophy: Cumulative 2 Year Interim Analysis of Open Label Study
(Faces)American Society for Dermatologic Surgery, INC 2012;38:1193-1205
Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-lactic acid for Treating
HIV-Associated Facial Lipoatrophy
Humble G, Mest D. Retreatment with Injectable Poly-L-Lactic Acid for HIV-Associated Facial Lipoatrophy: 24-Month
Extension of the Blue Pacific Study. Dermatologic Surgery 2009 Vol. 35 No. 1 Sp ed. Feb 2009
Humble G, Mest D. Injection Method Review and Evaluation for Injectable Poly-L-Lactic Acid for Treating HIVAssociated Facial Lipoatrophy Manuscript Submitted
Humble G, Mest D. Duration of Correction of Human Immunodeficiency Virus- Associated Lipoatrophy Following
Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plastic Surgery in Press
Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) injections in persons with HIV-Associated
Lipoatrophy: The US Experience: Derm Surg 2006 32;11:1336-1345
Humble G, Mest D. Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic
Dermatology 2006 19; 1:62-66
Humble G, Mest D, Englehard P. Safety of Sculptra: A
Review of Clinical Trial Data Journal of Cosmetic Laser Therapy 2005
Humble G, Mest, D. Soft Tissue Augmentation Using
Sculptra Facial Plastic Surgery 2004 20; 2:157-163
Humble G, Mest, D. Soft Tissue Augmentation Using
Silicone: An Historical Review Facial Plastic Surgery
2004 20; 2:181-184
Humble G, Filler Offers Longevity, Hope for Lipoatrophy Cosmetic Surgery Times 2005
Humble G, Treating Lipoatrophy with New Filler A Look at Successful Patient Cases Skin & Aging 2004
Humble G, FDA Ponders Approval of New-Fill For Wrinkles, Volume Loss Dermatology Times 2003 Vol. 24 No. 9
Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus- Associated Lipoatrophy After
Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654
Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of
the Blue Pacific Study. Dermatol Surg 2009 35:350-359
Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra Skin & Aging 2007; 15(10):
60-2
Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights In Press
Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated
Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345
Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic
Dermatology 2006 19; 1:62-66
Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 34:201-205
Abstracts:
Humble G, Mest D. Evaluation of the Cross Fanning Injection Method for Injectable Poly L-Lactic acid for Treating
HIV-Associated Facial Lipoatrophy (submitted)
Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related
Lipoatrophy: 1-Year Interim 5 Year Study Results, Summer AAD
Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related
Lipoatrophy: 2-Year Interim 5 Year Study Results, Summer AAD
Humble G, Mest D, Pierone G, Injectable Poly-L-Lactic Acid for Human Immunodeficiency Virus-Related
Lipoatrophy: 3-Year Interim 5 Year Study Results, Summer AAD
Humble G, Mest D, Interim Results of a 5-Year Open-Label Study for the Correction of HIV-Related Facial
Lipoatrophy with Injectable PLLA SDEF Hawaii Dermatology Meeting, Maui, HI 2009
Humble G, Mest D. Safety and Efficacy of Intradermal Poly-L-lactic acid (Sculptra) injections in patients with HIVAssociated Facial Lipoatrophy. Antiviral Therapy 2004; 9:L36
Humble G, Mest D. Poly L-Lactic Acid for the treatment of HIV-Associated Facial Lipoatrophy in Surgical Facial
Rejuvenation: Art and Clinical Practice, Ed. Shiffman M, Springer, Berlin In Press
Humble G, Mest D. Review and Evaluation of Treatment Procedures Using Injectable Poly-L-Lactic Acid in the
Treatment of HIV-Associated Facial Lipoatrophy Manuscript Submitted
Humble G, Mest D. Duration of Correction for Human Immunodeficiency Virus- Associated Lipoatrophy After
Retreatment with Injectable Poly-L-Lactic Acid. Aesthetic Plast Surg 2009 33; 4:654
Humble G, Mest D. Retreatment with injectable PLLA for HIV-Associated Facial Lipoatrophy: 24-Month Extension of
the Blue Pacific Study. Dermatol Surg 2009 35:350-359
Humble G, Mest D. A Recommended Approach to Cosmetic Enhancement with Sculptra. Skin & Aging 2007; 15
(10): 60-2
Humble G, Mest D, Conant M, Burgess, C. Poly-L-Lactic Acid for Facial Contouring: clinical insights
In Press
Humble G, Mest D, Safety and Efficacy of Poly-L-Lactic Acid (Sculptra) Injections in Persons with HIV-Associated
Lipoatrophy: The US Experience: Dermatol Surg 2006 32; 11:1336-1345
Humble G, Mest D, Human Immunodeficiency Virus-Associated Facial Lipoatrophy: A Review: Cosmetic
Dermatology 2006 19; 1:62-66
Humble G, Mest D, Englehard P, Safety of Sculptra: A Review of Clinical Trial Data J Cosm Laser Ther 2005 7; 34:201-205
Humble G, Mest D. Soft Tissue Augmentation Using Sculptra Facial Plastic Surgery 2004 20; 2:157- 163
Humble G, Mest D. Soft Tissue Augmentation Using Silicone: An Historical Review Facial Plastic Surgery 2004 20;
2:181-184
Professional Societies:
National Society of Cosmetic Physicians
American Academy of Cosmetic Surgeons
California Academy of Cosmetic Surgery
American Academy of Cosmetic Surgery
Council of Healthcare Advisors
Physician Advisory Board for Allergan
North American Academy of Cosmetic and Reconstructive Surgery
American College of Phlebology
American Society of Laser Medicine and Surgery
American Society of Anesthesiologists
Society of Ambulatory Anesthesiologists
American College of Physician Executives
World Anti-Aging Congress
The Aesthetic Practice Association
International Cellular Medicine Society
International Society for Stem Cell research